Variant position: 152 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 393 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human KMFCQLAKTCPVQLWVDSTP PPGTRVRAMAIYKQSQHMTEV
Rhesus macaque KMFCQLAKTCPVQLWVDSTP PPGSRVRAMAIYKQSQHMTEV
Mouse KLFCQLAKTCPVQLWVSATP PAGSRVRAMAIYKKSQHMTEV
Rat KLFCQLAKTCPVQLWVTSTP PPGTRVRAMAIYKKSQHMTEV
Pig KLFCQLAKTCPVQLWVSSPP PPGTRVRAMAIYKKSEYMTEV
Bovine KLFCQLAKTCPVQLWVDSPP PPGTRVRAMAIYKKLEHMTEV
Rabbit KLFCQLAKTCPVQLWVDSTP PPGTRVRAMAIYKKSQHMTEV
Sheep KLFCQLAKTCPVQLWVDSPP PPGTRVRAMAIYKKLEHMTEV
Cat KLFCQLAKTCPVQLWVRSPP PPGTCVRAMAIYKKSEFMTEV
Chicken KVYCRLAKPCPVQVRVGVAP PPGSSLRAVAVYKKSEHVAEV
Xenopus laevis KLFCQLAKTCPLLVRVESPP PRGSILRATAVYKKSEHVAEV
Zebrafish KLFCQLAKTCPVQMVVDVAP PQGSVVRATAIYKKSEHVAEV
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 393 Cellular tumor antigen p53
102 – 292
1 – 320 Interaction with CCAR2
100 – 370 Interaction with HIPK1
100 – 300 Required for interaction with ZNF385A
113 – 236 Required for interaction with FBXO42
116 – 292 Interaction with AXIN1
p53 gene mutations in Barrett's epithelium and esophageal cancer.
Casson A.G.; Mukhopadhyay T.; Cleary K.R.; Ro J.Y.; Levin B.; Roth J.A.;
Cancer Res. 51:4495-4499(1991)
Cited for: VARIANTS SPORADIC CANCERS LEU-152; ALA-155; HIS-175; PHE-176 AND HIS-273;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.